2-propylamino-benzenethiol | 98960-67-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯硫酚类
• 英文名称: 2-propylamino-benzenethiol
• 英文别名: 2-propylamino-thiophenol；2-(Propylamino)benzenethiol
• CAS: 98960-67-9
• 化学式: C₉H₁₃NS
• 分子量: 167.275
• InChiKey: NCHYWIINNBFRFA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  13
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-二甲氨基苯甲酰氯 、 2-propylamino-benzenethiol 生成 2-(4-dimethylamino-phenyl)-3-propyl-benzothiazolium; iodide
  参考文献：
  名称：

  驱虫性季盐。3.苯并噻唑盐。

  摘要：

  DOI：

  10.1021/jm00301a008
• 作为产物：
  描述：

  2-羟基苯并噻唑 在 氢氧化钾 、 sodium ethanolate 作用下， 生成 2-propylamino-benzenethiol
  参考文献：
  名称：

  Fujii, Yakugaku Zasshi/Journal of the Pharmaceutical Society of Japan, 1957, vol. 77, p. 3,5, 6

  摘要：

  DOI：

文献信息

• SUBSTITUTED PYRIMIDINE COMPOUNDS, COMPOSITIONS AND MEDICINAL APPLICATIONS THEREOF
  申请人：JUBILANT BIOSYS LIMITED

  公开号：US20160207905A1

  公开（公告）日：2016-07-21

  The present disclosure relates to pyrimidine compounds of formula (I), their stereoisomers, tautomers, pharmaceutically acceptable salts, polymorphs, solvates, and hydrates thereof. The present disclosure also relates to process of preparation of these pyrimidine compounds, and to pharmaceutical compositions containing them. The compounds of the present disclosure are useful in the treatment, prevention or suppression of diseases and disorders mediated by epidermal growth factor receptor (EGFR) family kinases.

  本公开涉及式（I）的嘧啶化合物，它们的立体异构体，互变异构体，药学上可接受的盐，多晶形，溶剂化物和水合物。本公开还涉及制备这些嘧啶化合物的过程，以及含有它们的制药组合物。本公开所述化合物在治疗，预防或抑制由表皮生长因子受体（EGFR）家族激酶介导的疾病和疾病方面具有用处。
• Substituted Fused Pyrimidine Compounds
  申请人：Advinus Therapeutics Private Limited

  公开号：US20150087643A1

  公开（公告）日：2015-03-26

  The present invention discloses substituted fused pyrimidine compounds of formula (I), their tautomers, polymorphs, stereoisomers, solvates, pharmaceutically acceptable salts, or pharmaceutical compositions containing them and methods of treating conditions and diseases that are mediated by adenosine receptor (AR) activity; the compounds of the present invention are useful in the treatment, prevention or suppression of diseases and disorders that may be susceptible to improvement by antagonism of the adenosine receptor, such as asthma, chronic obstructive pulmonary disorder, angiogenesis, pulmonary fibrosis, emphysema, allergic diseases, inflammation, reperfusion injury, myocardial ischemia, atherosclerosis, hypertension, congestive heart failure, retinopathy, diabetes mellitus, obesity, inflammatory gastrointestinal tract disorders, and/or autoimmune diseases.

  本发明揭示了式（I）的取代融合嘧啶化合物，它们的互变异构体、多晶形、立体异构体、溶剂化物、药学上可接受的盐或含有它们的制药组合物以及治疗通过腺苷受体（AR）活性介导的疾病和病症的方法；本发明中的化合物在治疗、预防或抑制疾病和疾病方面有用，这些疾病和疾病可能通过拮抗腺苷受体而容易改善，例如哮喘、慢性阻塞性肺疾病、血管生成、肺纤维化、肺气肿、过敏性疾病、炎症、再灌注损伤、心肌缺血、动脉粥样硬化、高血压、充血性心力衰竭、视网膜病变、糖尿病、肥胖、炎症性肠道疾病和/或自身免疫性疾病。
• PHTHALOCYANINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND OPTICAL RECORDING MEDIUM CONTAINING THE SAME
  申请人：MITSUI CHEMICALS, INC.

  公开号：EP1482013A1

  公开（公告）日：2004-12-01

  A phthalocyanine compound represented by the following general formula (I) and the mixture thereof, and an optical recording medium containing the compound/mixture in its recording layer. wherein in formula (I), M is two hydrogen atoms, a divalent metal atom, a mono-substituted trivalent metal atom, a di-substituted tetravalent metal atom, or an oxymetal, and L1, L2, L3 and L4 are each independently formula (a), formula (b), or formula (c) : in formula (a), formula (b), and formula (c), X represents a substituted or unsubstituted alkyl group, alkoxy group, alkylthio group, aryloxy group, and arylthio group, Rs are each independently a hydrogen atom, a substituted or unsubstituted alkyl group with 1-6 of total carbon numbers, a substituted or unsubstituted aryl group with 6-10 of total carbon numbers, A represents a carbonyl group, a thiocarbonyl group, a sulfone group, a sulfine group, or a carboimidoyl group, Y represents a metal compound residue, and Z represents independently a hydrogen atom, a nitro group, or a halogen atom, and at least one of L1-L4 is formula (a) or (b).

  由以下通式(I)表示的酞菁化合物及其混合物，以及在其记录层中含有该化合物/混合物的光学记录介质。 其中，在式 (I) 中，M 是两个氢原子、二价金属原子、一取代三价金属原子、二取代四价金属原子或氧金属；L1、L2、L3 和 L4 各自独立地为式 (a)、式 (b) 或式 (c) ： 在式(a)、式(b)和式(c)中，X 代表取代或未取代的烷基、烷氧基、烷硫基、芳氧基和芳硫基，Rs 各自独立地为氢原子、总碳数为 1-6 的取代或未取代的烷基、A 代表羰基、硫代羰基、砜基、硫基或羧酰亚胺基，Y 代表金属化合物残基，Z 独立地代表氢原子、硝基或卤素原子，L1-L4 中至少有一个是式 (a) 或 (b)。
• FLUORESCENT DYE, PREPARATION METHOD THEREFOR AND USE THEREOF
  申请人：Shenzhen University

  公开号：EP3744810A1

  公开（公告）日：2020-12-02

  Disclosed are a fluorescent dye, a preparation method and an application thereof. The fluorescent dye has a general structural formula as shown in formula (I), wherein X and Y are same or different and selected from O, S, C(CH3)2 or NR6; R2 and R3 are the same or different and selected from hydrogen or a functional group; R1, R4, R5 and R6 are all functional groups; and Z- is a negative ion. The fluorescent dye has an ability to permeate the living cell membrane, so that it can be used in the fluorescence imaging of living cell microstructures, and can also be used in the STED super-resolution fluorescence imaging and laser scanning confocal microscopy of live cells.

  本发明公开了一种荧光染料及其制备方法和应用。该荧光染料的结构通式如式（I）所示，其中X和Y相同或不同，选自O、S、C(CH3)2或NR6；R2和R3相同或不同，选自氢或官能团；R1、R4、R5和R6均为官能团；Z-为负离子。该荧光染料具有渗透活细胞膜的能力，因此可用于活细胞微结构的荧光成像，也可用于活细胞的 STED 超分辨率荧光成像和激光扫描共聚焦显微镜。
• Phthalocyanine compound, process for producing the same, and optical recording medium containing the same
  申请人：Seino Kazuhiro

  公开号：US20050201265A1

  公开（公告）日：2005-09-15

  A phthalocyanine compound represented by the following general formula (I) and the mixture thereof, and an optical recording medium containing the compound/mixture in its recording layer. wherein in formula (I), M is two hydrogen atoms, a divalent metal atom, a mono-substituted trivalent metal atom, a di-substituted tetravalent metal atom, or an oxymetal, and L 1 , L 2 , L 3 and L 4 are each independently formula (a), formula (b), or formula (c): wherein X, Y, Z and R are defined.